Showing all 2 results

Placeholder

Hepcinat Plus is a fixed-dose combination tablet developed by Natco Pharma Ltd for the treatment of chronic hepatitis C virus (HCV) infection. This formulation combines two antiviral agents—Sofosbuvir 400 mg and Daclatasvir 60 mg—into a single tablet, simplifying the treatment regimen for patients.

Hepcinat Plus Tablet by natco Pharma  Details:

Category Antiviral drug
Brand Natco
Ingredient Sofosbuvir
Prescription Required Yes
Strength 60/400mg
Package 28 Tablets
Placeholder

Pirfenex is a brand of Pirfenidone tablets manufactured by Cipla Ltd, primarily used in the treatment of Idiopathic Pulmonary Fibrosis (IPF), a chronic lung disease characterized by progressive scarring of lung tissue.

Pirfenex 200mg by Cipla Pharma Details :

Category Idiopathic Pulmonary Fibrosis (IPF)
Brand Cipla
Ingredient Pirfenidone
Prescription Required Yes
Strength 200mg
Package 10 Tablets